Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review
ConclusionEarly evidence suggests that dapagliflozin and empagliflozin are well tolerated in children. A clinical pharmacology rationale currently exists only for adolescents with diabetes mellitus.Prospero Registration NumberCRD42023438162.
Source: Pediatric Drugs - Category: Pediatrics Source Type: research
More News: Cardiology | Children | Chronic Kidney Disease | Clinical Trials | Dapagliflozin | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Empagliflozin | Endocrinology | Forxiga | Gastroenterology | Heart | Heart Failure | Jardiance | Pediatrics | Science | Sodium | Study | Toxicology | Urology & Nephrology